Articles and Blogs

On Tuesday May 9, 2023, the Drug Enforcement Administration (“DEA”), jointly with the Substance Abuse and Mental Health Services Administration (“SAMHSA”), announced that it will publish a rule to temporarily extend current telemedicine flexibilities for prescribing controlled substances beyond the termination of the Federal Public Health Emergency (“PHE”), which will occur on May 11,... READ MORE

On May 1, 2023, the Quality, Safety & Oversight Group at CMS issued a memorandum entitled “Guidance for the Expiration of the COVID-19 Public Health Emergency (PHE)” (the “CMS Memo”) which announced that certain regulations or other policies included in the Interim Final Rules during the public health emergency (“PHE”) will be modified with the... READ MORE

On Friday, February 24, 2023, the Drug Enforcement Administration (“DEA”) proposed new regulations that would permanently allow for telemedicine-controlled substance prescriptions, including induction of medication assisted therapy (“MAT”) using buprenorphine. These long-awaited rules will be subject to an accelerated, 30-day notice and comment period that ends March 31, 2023 to allow for implementation prior... READ MORE

Medicare payment policy changes established under the CMS CY 2023 Medicare Physician Fee Schedule (“MPFS”) Final Rule, issued on November 1, 2022, become effective January 1, 2023. Below is a high-level summary of significant changes established for 2023. Evaluation and Management (E/M) Visits Over the past several years, CMS engaged in efforts with the... READ MORE

Under the recent Wisconsin COVID-19 relief law, 2019 Wisconsin Act 185 (effective April 17, 2020) (the “ Relief Act”), and pursuant to the Federal Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), temporary emergency unemployment benefits have been made available to claimants and employers in Wisconsin. The Relief Act accomplishes a number... READ MORE

On April 30, 2020, CMS published guidance in a second Interim Final Rule (“IFR”) addressing regulatory flexibilities available to hospitals to bill for hospital/critical access hospital outpatient therapeutic services on the UB-04 when such services are furnished in a temporary expansion location (including a beneficiary’s home) during the COVID-19 public health emergency (“PHE”). This... READ MORE